Discover
RLMD
Relmada Therapeutics, Inc.
6.39
2 x 4.95
2 x 8.15
bid
ask
-
0.53
7.66%
2 @ 04:00 PM
6.35 -0.04 (0.63%)
| Ytd | 32.30% | |
| 1y | 963.23% |
6.30
day range
6.97
0.55
52 week range
8.00
| Open | 6.88 | Prev Close | 6.92 | Low | 6.30 | High | 6.97 | Mkt Cap | 670.87M |
| Vol | 1.87M | Avg Vol | 1.58M | EPS | -1.09 | P/E | N/A | Forward P/E | -0.19 |
| Beta | 0.41 | Short Ratio | 4.52 | Inst. Own | 46.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 6.93 | 200-d Avg | 4.81 | 1yr Est | 0.87 |
| Income Statement | |||
| Operating Expenses | 19.46M | ||
| Research and Development Expense | 8.09M | ||
| Selling, General and Administrative Expense | 11.37M | ||
| Operating Income | -19.46M | ||
| Net Income | -19.05M | ||
| Net Income Common Stock | -19.05M | ||
| Net Income Common Stock (USD) | -19.05M | ||
| Consolidated Income | -19.05M | ||
| Earnings per Basic Share | -0.22 | ||
| Earnings per Basic Share (USD) | -0.22 | ||
| Earnings per Diluted Share | -0.22 | ||
| Earning Before Interest & Taxes (EBIT) | -19.05M | ||
| Earning Before Interest & Taxes (USD) | -19.05M | ||
| Weighted Average Shares | 86.60M | ||
| Weighted Average Shares Diluted | 86.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.78M | ||
| Cash and Equivalents (USD) | 9.78M | ||
| Investments | 224.19M | ||
| Investments Current | 224.19M | ||
| Current Assets | 235.34M | ||
| Total Assets | 235.36M | ||
| Current Liabilities | 12.89M | ||
| Total Liabilities | 16.63M | ||
| Accumulated Retained Earnings (Deficit) | -717.32M | ||
| Shareholders Equity | 218.73M | ||
| Shareholders Equity (USD) | 218.73M | ||
| Assets Non-Current | 19.50K | ||
| Liabilities Non-Current | 3.74M | ||
| Trade and Non-Trade Payables | 5.73M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 156.57M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.28M | ||
| Issuance (Purchase) of Equity Shares | 156.64M | ||
| Net Cash Flow from Investing | -135.23M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -135.23M | ||
| Net Cash Flow from Operations | -15.07M | ||
| Share Based Compensation | 3.63M | ||